BioXcel Therapeutics Inc

:BTAI

1.49

-0.06 (-3.87%)

7:50:15 PM EDT: $1.51 +0.02 (+1.34%)

Market Cap (Intraday)	31.32M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.15 Million
Adjusted EPS	-$0.64

See more estimates

10-Day MA	$1.58
50-Day MA	$1.69
200-Day MA	$2.27

See more pivots

BioXcel Therapeutics Inc Stock, :BTAI

555 Long Wharf Drive, 12th floor, New Haven, Connecticut 06511

United States of America

Phone: +1.475.238.6837

Number of Employees: 74

http://www.bioxceltherapeutics.com

Description

BioXcel Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of artificial intelligence solutions in neuroscience and immuno-oncology. It also focuses on utilizing technology and research to develop therapeutics solutions. The company was founded by Vimal D. Mehta on March 29, 2017 and is headquartered in New Haven, CT.